EXELIXIS GROUP
EXELIXIS GROUP
Organization chart 2
Our product portfolio 3
Who are we 1
A closer look 4
Organization chart 2
Our product portfolio 3
Who are we 1
Our History Our Vision Our Strategy
A closer look 4
4
EXELIXIS S.A. established in Athens, Greece to serve the local public and private HC sector
Earns accreditation by the EU Quality System Certificate ISO 9001/2000 & ISO 13485
EXELIXIS S.A teams with major group of companies with various activities and annual turnaround of USD 25.00 Mio
EXELIXIS S.A. enters MDx & ART markets in GR, through exclusive agreements and establishes distribution points in SEE
EXELIXIS S.A. acquires Consumer Medicine Division formerly known as Gerolymatos OTC, and enters OTC & Rx markets
Rolls our Business Plan for business development in M. East – N. Africa
1993
2004
2000
2010
2013
2009
Who are we | Our History
Deliver True Value
Provide H/C professionals with Diagnostic and Medical solutions of established value, for the benefit of all patients, worldwide.
Clinical value
Pharmaceutical value
Financial Value
Innovation
Offer complete solutions that allow our commercial partners to use their full potential, grow their existing business and expand.
Produce pharmaceutical products and food supplements that deliver measurable results, allowing all consumers to live healthier lives.
Consistently deliver innovative Diagnostics and Pharmaceuticals that continuously drive diagnosis and clinical management forward.
Who are we | Our Vision
5
Continuously improve and innovate our VITAL® and other owned brands
Further strengthen our presence in SEE via improving current colla-borations
Launch new product lines to address OBGYN market
Expand to MENA markets via commercial partners
EXELIXIS Health & Care
Increase market pene-tration at the private H/C sector level
Launch complete solutions for infectious diseases & personalized healthcare
Build on successful product range for IVF and expand menu offer
Expand operations in MENA via partner-tailored solutions
EXELIXIS Diagnostics
Leverage existing OBGYN network to strengthen the Group’s global presence
Drive expansion of Future Health Stem Cell Banking into new geographical markets via commercial partners
Group affiliations
Turnkey solutions for accelerated growth & revenue streams, via Rx-Dx synergies, and a holistic approach to Marketing & Sales
Who are we | Our Strategy
Our three growth drivers:
6
Organization 2
Our product portfolio 3
Who are we 1
A closer look 4
Organization | EXELIXIS Group
8
Board of Directors
Managing Director
Commercial Director Marketing Director
Global Business
Development
Commercial Director Marketing Director
Quality Control Credit Control Legal IT Support
Our product portfolio 3
Organization 2
Who are we 1
A closer look 4
Our product portfolio | Products Overview
Complete Laboratory Automation
Molecular Diagnostics Portfolio
□ Infectious Diseases
□ Personalized Medicine
□ Cancer
□ STIs
Assisted Reproduction Solutions
□ DNA Fragmentation
□ Semen Analysis
□ IVF/ICSI Culture Media
Medical Devices
□ IVF Needles & Catheters
□ ICSI Micropipettes
□ Intrauterine contraceptives
Microbiology & Clinical Chemistry
EXELIXIS Health & Care
Nutraceuticals
□ VITAL® plus Q10
□ VITAL plus Q10 Effervescent®
□ VITAL Silver®
□ VITAL Cardio®
□ VITAL Memo®
□ VITAL Cold®
□ Lacroflora®
Rx
□ ANTIS®
□ Saribal®
□ Lataneau®
Diabetes Monitoring
□ Infopia®
EXELIXIS Health & Care
A global Stem Cell bank company
Present in 29 countries, with access to 35,000 obstetricians and gynecologists
Complete Stem Cell storage solution for families
□ Cord Blood cells
□ Cord Tissue cells
□ Tooth cells
□ Adipose tissue cells
EXELIXIS Health & Care
Diagnostic & Med. devices Pharmaceutical Stem Cell BioBank
A closer look 4
Organization 2
Who are we 1
Our Dx solutions Our Pharma solutions Future Health BioBank
Our product portfolio 3
A closer look | Our Dx solutions
OB/GYN Fertility clinics Dx / Gx centers
Intrauterine insemination IUI preparation kit Consumables
Contraceptives (IUD) PROM detection Fertility evaluation
Sperm DNA fragment.
Complete ART solutions Oocyte retrieval IVF/ICSI procedures Embryo implantation
Fertility evaluation Sperm DNA fragment. Semen analysis
Laboratory automation Infectious diseases
Respiratory TPx
Cancer genetics Fertility evaluation
Sperm DNA fragment. Semen analysis
Ap
plic
atio
ns
A closer look | Our Dx solutions
Intrauterine Contraceptive Devices
Top-selling Contraceptives
High quality devices, manufactured in EU, individually packaged and sterilized
Indicated for intrauterine contraception
Copper-based, without hormonal additives
Recommended removal period of 5 years
IUD portfolio:
□ LOAD 375 – anchor-shaped, industry standard
□ UT 380 Standard | Short – T-shaped
□ TT 380 Standard | Mini – the single smallest IUD on the market , for nulliparous women
□ NT 380 Standard | Short – Silver-coated for copper intolerance
Come complete with packaging
Instructions for doctors and patients
A closer look | Our Dx solutions
Challenge Innovation Solution Markets
Couples with normal semen parameters (M), and hormonal profile (F) are unable to conceive naturally or through Assisted Reproduction. Cases referred to as “unex-plained infertility”.
Extensive R&D by Halotech DNA reveals that the degree of sperm DNA fragmen-tation plays a major role in the success rate of conception (either natural or assisted).
The Halosperm® assay allows for the easy, quick and accurate measurement of DNA fragmentation in semen. Halosperm® is now offered as a standard test in Dx and Fertility centers.
The Halosperm® solution is available for human semen evaluation in ART. In Veterinary semen testing, Halomax® is used to assess the reproductive capacity of breeding males.
Key Benefits: □ Disruptive innovation □ High Diagnostic value □ High Clinical value □ Entry point into IVF &
Veterinary markets
A closer look | Our Dx solutions
ICSI Micropipettes
Holding Injection Hatching Biopsy Denuding
A closer look | Our Dx solutions
Molecular Diagnostics Portfolio
Innovative multiplexing technology Broad CE-IVD portfolio
Respiratory infectious agents RespiFinder® SMART 22
Bacterial CNS infections MeningoFinder® SMART 7
Sexually transmitted infections STD-Finder® SMART 7
HPV typing PapillomaFinder® SMART 20
Established , reputable IVD solutions Broad RT-PCR Dx portfolio
STD virii Bacterial menengitis Complete Herpes panel Gastrointestinal infections Respiratory pathogens Controls A
pp
licat
ion
s
A closer look 4
Organization 2
Who are we 1
Our Dx solutions Our Pharma solutions Future Health BioBank
Our product portfolio 3
A closer look | Our Pharma solutions
Nutraceuticals
Pharmacy channel OTC (non-prescribable) Whole sales
Rx
Pharmacy channel OTC (non-prescribable) Whole sales
Prescribable
Pharmacy channel Prescribable medicines Whole sales
Food supplements Nutraceuticals Probiotic supplements
Antitussive syrups Mycolytic syrups Dermocosmetics Mouth ulcer treatment
Diabetes monitoring Anti-glaucoma eye drops
Mar
ket
acce
ss
Ap
plic
atio
ns
A closer look | The VITAL® brand
The VITAL® brand – Values
VITAL® plus Q10 VITAL® plus Q10 Effervescent
VITAL® Silver VITAL® Cardio
VITAL® Memo VITAL® Cold
Guaranteed effectiveness Selective combination of components and unique microelement formulations Key components
High concentration of Ginsenosides & Eleutherococcus senticoccus LipidCaps™ System Patented, innovative pharmaceutical-form capsule that conceals odours and prevents
gastric aggression, while simultaneously ensures optimal oral bioavailability Safe Products & Effective Formulas:
Quality ensured and regularly monitored by International accreditation bodies
A closer look | The VITAL® brand
The VITAL® brand – Main Consumer Categories
Individuals with demanding daily schedule Not balanced diet with frequent omission of vital dietary ingredients (e.g. fruits,
vegetables etc.) Increased need for antioxidants Athletes Bigger needs in nutritious components Need of protection from metabolic stress that cause the exercise Students Need for improvement of intellectual output and cope with stress People that feel the need to support and enhance their Immune System
Men and Women who experience stress, fatigue and lack vitality
A closer look | The VITAL® brand
The VITAL® brand – Special Consumer Categories
Vegetarians (usually deficient in Iron, Calcium, L-carnitine) Individuals under weight-loss diet Individuals facing medical conditions: Anorexia Hyperlipidemia (supplementary Co-enzyme Q10 is a requirement in antilipidemic
medication, also need of antioxidants) Diabetes type-2 (Documented lower levels of Co-enzyme Q10 in blood stream,
also elevated need for antioxidants due to oxidative stress ) Hypothyroidism (present lack of energy, and often under weight-loss diet )
Men & Women under strict diet and individuals with chronic health conditions
A closer look | The VITAL® brand
The VITAL® brand – Special Consumer Categories
Increased needs in antioxidant components Decreased endogenous production CoQ10 Decreased engagement of nutritious components because problems in feeding Increased needs in calcium and same vitamin D Decreased absorption of micronutrients components due to general
gastrointestine dysfunction Increased needs in micronutrients components due to frequent use of medicines Onset of degenerative disorders
Middle-aged and Elderly Men and Women
A closer look | The Lactoflora® brand
A brand new, unique dietary supplement featuring a combination of probiotics microorganisms that help restore and maintain a healthy flora of the intestine
Lactoflora® can be used adjunctively to antibiotic treatment
Lactoflora® – Product Overview
Posi
tio
nin
g
Available in box of 10 & 20 capsules
Key
In
gred
ien
ts
Pack
g.
A closer look | The Lataneau® brand
Latanoprost (prostagladin analogue) 0,005% w/v in eye-drop solution
Lataneau®
Act
ive
Ingr
edie
nt
Open Angle Glaucoma Raised pressure in the eye (ocular hypertension).
Ind
icat
ion
s
Lataneau lowers the pressure in the eye that results from fluid accumulation and can subsequently lead to Glaucoma
Glaucoma affects ca. 12 Mio people in Europe alone and is the most common cause of blindness D
escr
ipti
on
Non-Productive
Cough
Productive
A closer look | Anti-cough drugs
Butamirate citrate 7,5mg / 5ml A
ctiv
e In
gred
ien
t
Sugar-free It has a pleasant vanilla flavor It does not have serious side effects Fe
atu
res
Ambroxol Hydrochloride 30mg / 5ml
Sugar-free It has a pleasant mint flavor It does not have serious side effects
25
26
A closer look | Our complete Pharma portfolio
A closer look 4
Organization 2
Who are we 1
Our Dx solutions Our Pharma solutions Future Health BioBank
Our product portfolio 3
A closer look| Future Health BioBank
Future Health BioBank
The first private family cord blood bank to receive a full accreditation as a human tissue bank by the MHRA UK
Own purpose built laboratories in the UK & Switzerland
Accredited by
□ MHRA (Medicines & Healthcare products Regulatory Agency)
□ HTA (Human Tissue Bank)
□ MHRA BEA (Blood Establishment Authorization)
□ cGMP / ISO / GLP
Winner of The Queen’s Award for Enterprise 2010
Offers the broadest range solutions for stem cell storage
Parents receive Collection kit
Parents bring Collection kit to labour ward on
labour day
Labour ward staff collect and store cord blood cell sample in
Collection kit
Collection kit is shipped to Future
Health BioBank
Future Health BioBank scientific
team isolates stem cells
Stem cells stored by Future Health
Biobank for 25 years
Thank you!
29